EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of the gut microbiota metabolite phenylacetylglycine on cardiac Ca2+ signaling

Elisa Bovo, Aleksey V Zima

Biophysical Reports · 2026-06 · 6 (2) · 100260

DOI: 10.1016/j.bpr.2026.100260 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysical Reports, 2026-06. Verfasst von Elisa Bovo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell & Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Calcium Signaling, Glycine, Microbiota. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phenylacetylglutamine (PAGln) and phenylacetylglycine (PAGly) are small molecules derived from the metabolism of phenylalanine by gut microbiota. Elevated levels of PAGln and PAGly in serum have been associated with increased risks for cardiovascular diseases. It has been suggested that PAGln and PAGly reduce cardiac contraction by blunting the adrenergic response during sympathetic stimulation. However, little is known about whether the effect of PAGln and PAGly on the heart function is associated with an alteration of intracellular Ca2+ homeostasis. Here, we studied the effect of PAGly on Ca2+ regulation in mouse ventricular myocytes, as PAGly is the predominant phenylalanine metabolite in rodent's serum. Analysis of cytosolic Ca2+ dynamics revealed that PAGly (100 μM) increases action potential-induced Ca2+ transients and sarcoplasmic reticulum Ca2+ load. These effects of PAGly were significantly smaller than those produced by the adrenergic receptor agonist isoproterenol (ISO; 0.1 μM). The adrenergic receptor blocker propranolol (10 μM) and the protein kinase A inhibitor H89 (10 μM) prevented the PAGly effects on intracellular Ca2+ dynamics. Further analysis of Ca2+ regulation revealed that pretreatment of cardiomyocytes with PAGly reduced the stimulatory effect of ISO on intracellular Ca2+ dynamics. Concurrently, PAGly did not produce any stimulatory effects on intracellular Ca2+ in the presence of ISO. In conclusion, PAGly regulates intracellular Ca2+ dynamics in ventricular myocytes by activating the adrenergic receptor-mediated signaling, but less efficiently than selective adrenergic agonists. By interacting with adrenergic receptors, PAGly might blunt the stimulatory effect of sympathetic stimulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacCalcium SignalingGlycineMicrobiotaAnimalsMiceIsoproterenolCalciumMaleMice, Inbred C57BL

Substanzen

GlycineIsoproterenolCalcium

Autor:innen und Institutionen

  • Department of Cell & Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
  • Department of Cell & Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA. Electronic address: azima@luc.edu.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health

Zitieren

APA

Bovo, E., & Zima, A. V. (2026). Effect of the gut microbiota metabolite phenylacetylglycine on cardiac Ca2+ signaling. Biophysical Reports, 6(2), 100260. https://doi.org/10.1016/j.bpr.2026.100260

Vancouver

Bovo E, Zima AV. Effect of the gut microbiota metabolite phenylacetylglycine on cardiac Ca2+ signaling. Biophysical Reports. 2026;6(2):100260. doi:10.1016/j.bpr.2026.100260

BibTeX
@article{Bovo2026,
  author = {Bovo, Elisa and Zima, Aleksey V},
  title = {Effect of the gut microbiota metabolite phenylacetylglycine on cardiac Ca2+ signaling},
  journal = {Biophysical Reports},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {100260},
  doi = {10.1016/j.bpr.2026.100260}
}
Kostenlos starten →